COMPANY

AbSci

HQ: Vancouver, WA source · absci.com ↗ · West Coast

Clinical Phase 2

Also known as Absci Pty Ltd. · 9 open jobs · last seen Oct 23, 2026 · 5 sources

Keywords: antibody androgenic alopecia Androgenetic Alopecia

Location: Vancouver, WA · source · Oct 15, 2026

Profile checked Oct 10, 2026

Since the raise (Jun 24, 2026): 9 of 9 open jobs were first seen after it.

9Open jobs $150.0MRaised (2 yrs)1Trials (company is sponsor)

Hiring

Title	Location (from posting)	Employer posted	First seen
Associate Dir, Protein Sciences	Vancouver, WA, USA	Oct 22, 2026	Oct 23, 2026
Staff/Principal AI Scientist - Virtual Tissue	United States	Oct 19, 2026	Oct 8, 2026
Drug Discovery Resource Outsourcing Manager	United States	Oct 9, 2026	Oct 10, 2026
Vice President, Clinical Operations	United States	Sep 29, 2026	Oct 8, 2026
Senior Director, Inspection Readiness	United States	Sep 22, 2026	Oct 8, 2026

See all 9 jobs

Timeline

Oct 8, 2026 Board tracked Radar started tracking this company’s job board (9 open jobs at last check). source ↗
Jun 24, 2026 Raise Follow-on offering: $100M (total, as published), announced Jun 24, 2026. Source: SEC filing. source ↗
Dec 3, 2025 Trial start Phase 1/Phase 2: Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Adults With and Without Androgenetic Alopecia source ↗
Jul 24, 2025 Raise Follow-on offering: $50M (total, as published), announced Jul 24, 2025. Source: SEC filing. source ↗
Jan 8, 2025 Raise Private placement: amount not published, announced Jan 8, 2025. Source: company release on GlobeNewswire. source ↗

Upcoming milestones

2028-07 (ESTIMATED) · Phase 1/Phase 2 · Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Adults With and Without Androgenetic Alopecia · NCT07317544

Estimated primary completion per ClinicalTrials.gov. Dates move.

Open jobs 9

Title	Location (from posting, not HQ)	Employer posted	First seen	Level
Associate Dir, Protein Sciences	Vancouver, WA, USA	Oct 22, 2026	Oct 23, 2026	Not stated
Staff/Principal AI Scientist - Virtual Tissue	United States	Oct 19, 2026	Oct 8, 2026	Not stated
Drug Discovery Resource Outsourcing Manager	United States	Oct 9, 2026	Oct 10, 2026	Mid
Vice President, Clinical Operations	United States	Sep 29, 2026	Oct 8, 2026	Executive
Senior Director, Inspection Readiness	United States	Sep 22, 2026	Oct 8, 2026	Senior
Sr. Manager Quality	United States	Sep 17, 2026	Oct 8, 2026	Senior
Director, Regulatory & Compliance	United States	Sep 16, 2026	Oct 8, 2026	Senior
Clinical Trial Manager	United States	Sep 15, 2026	Oct 8, 2026	Mid
Senior/Staff AI Scientist, Antibody Design	United States	Aug 21, 2026	Oct 8, 2026	Mid

Level (Entry/Mid/Senior/Executive) is estimated from the job title and required years of experience. Descriptions are short excerpts (about the first 60 words) of the posting plus skills picked out of it; use Read full posting for the complete text.

Funding

Raised: $150.0M. Last 2 years.

Jun 24, 2026 Follow-on offering: $100M (total, as published), announced Jun 24, 2026. Source: SEC filing. source ↗
Jul 24, 2025 Follow-on offering: $50M (total, as published), announced Jul 24, 2025. Source: SEC filing. source ↗
Jan 8, 2025 Private placement: amount not published, announced Jan 8, 2025. Source: company release on GlobeNewswire. source ↗

Clinical trials (lead sponsor) 1

Record	Title	Phase	Status	Start	Primary completion
NCT07317544	Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Adults With and Without Androgenetic Alopecia	Phase 1/Phase 2	Recruiting	Dec 3, 2025	2028-07 (estimated)

Connect

See your connections at AbSci on LinkedIn (search by name, results not checked)

LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.

LinkedIn page linked from the company's own site: source · seen 2026-10-18